好孕行生醫

iPreg

好孕行生醫股份有限公司 ( iPreg Inc.) 成立於2018年，是專注於生殖醫學的生醫設備製造商，利用精子的生理特性，研發一款精子仿生分選裝置「SperŜort™Biochip」，旨在改善精子品質，支持不孕症治療並提升懷孕成功率，並降低遺傳與生殖風險，致力於將高品質、具科學實證的生殖醫學產品推向全球市場。

目前已於2023年取得ISO13485醫療器材製造認證；2024年取得台灣TFDA與QMS；2025年2月取得美國FDA。

iPreg Inc. is founded in 2018, dedicated to providing advanced reproductive medicine solutions, with its core technology centered on the proprietary SperŜort™Biochip, a sperm selection microchip designed to enhance the success rate of assisted reproductive treatments (IVF) while reducing genetic and reproductive risks. Headquartered in Taiwan, iPreg Inc. is committed to delivering high-quality, scientifically validated reproductive medicine products to the global market.

The company obtained ISO 13485 medical device manufacturing certification in 2023, TFDA and QMS certification in Taiwan in 2024, and FDA approval in the United States in February 2025.